CDKN1A and cancer: Increased level of cytoplasmic p21 in AKT-activated cancer cells contributes to cancer cell survival and drug resistance, suggesting the role of oncogenic p21 in apoptosis-resistant phenotypes of PTEN-deficient tumors 11.